Drug intelligence / Profile preview

coagulation factor IXa recombinant

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

**Coagulation factor IXa recombinant** is a recombinant form of activated human coagulation factor IX, a serine protease in the intrinsic coagulation cascade. In physiology, factor IXa complexes with activated factor VIII on phospholipid surfaces in the presence of calcium to form the intrinsic tenase complex, which activates factor X to factor Xa and thereby amplifies thrombin generation and fibrin clot formation. As a therapeutic concept, recombinant factor IX products are well established for hemophilia B, but marketed products are generally recombinant factor IX zymogen rather than activated recombinant factor IXa specifically; therefore the query most likely refers to an activated mechanistic form or a nonstandard/experimental designation rather than a clearly marketed standalone drug product.

Other names
recombinant factor IXarecombinant activated factor IXactivated coagulation factor IX recombinantcoagulation factor IXa recombinant
02

Targets

PS (Phosphatidylserine)F10 (Factor Xa)F8 (Coagulation Factor VIIIa)

Beyond the preview

Go deeper on coagulation factor IXa recombinant.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on coagulation factor IXa recombinant.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call